Revelation Biosciences, Inc
1 clinical trials · Sponsor
◉ Watch Revelation Biosciences, Inc
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease. (NCT06863467) | Revelation Biosciences, Inc | 2025-01-20 |
Track Revelation Biosciences, Inc automatically
Every clearance here is in the API, with alerts when new ones post.